PITTSBURGH, Feb. 14, 2024 – It was a last-ditch effort. For years doctors had tried to keep a patient’s recurrent drug-resistant bacterial blood infection at bay, but it kept coming back and ...

Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering ...

Peering through his microscope in 1910, Franco-Canadian microbiologist Félix d'Hérelle noticed some "clear spots" in his bacterial cultures, an anomaly that turned out to be viruses preying on the ...

Bacteriophages have been used therapeutically to treat infectious bacterial diseases for over a century. As ...

The public are in favor of the development of bacteria-killing viruses as an alternative to antibiotics – and more efforts to educate will make them significantly more likely to use the treatment, a ...

LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of ...

A new study from scientists at New York University, Yale University, and elsewhere has demonstrated that several phage species can coexist stably on a genetically uniform strain of E. coli. They ...

Bacteriophages have been used therapeutically to treat infectious bacterial diseases for over a century.

Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering system for Pseudomonas aeruginosa, an antibiotic-resistant bacterium of ...